// company-profile

CNS Pharmaceuticals, Inc.

CNSP
ExchangeNasdaqSectorPharmaceutical PreparationsInc.NVFilings48Insiders14
// api This CNS Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, CNS Pharmaceuticals, Inc. insiders bought $34K across 1 transaction with no open-market sales.

  • Most active insider: Charles Faith L. with 1 transaction totaling $34K.
  • Largest single purchase: $34K by Charles Faith L. on May 18, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of CNS Pharmaceuticals, Inc. as of 2026-03-31

— stable
Total reported AUM
$348,663
QoQ change
Reporting period
2026-03-31
#1
Stonepine Capital Management, LLC
CIK 1440771
$145,790
61K shares
#2
Ikarian Capital, LLC
CIK 1778253
$109,992
46K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$54,825
23K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 18, 2026Charles Faith L.CNSP
Purchase
7,100$4.79$34K
Mar 2, 2026O'Loughlin SteveCNSP
Award
9,500
Mar 2, 2026Faulkner EricCNSP
Award
9,500
Jan 1, 2026Levin RamiCNSP
Award
19,000
Nov 17, 2025Climaco John MCNSP
Award
9,761$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.